The rodent liver displays marked age-and sex-dependent changes in androgen sensitivity due to the sexually dimorphic and temporally programmed expression of the androgen receptor (AR) gene. We have altered this normal phenotype by constitutive overexpression of the rat AR transgene in the mouse liver by targeting it via the human phenylalanine hydroxylase (hPAH) gene promoter. These transgenic animals in their heterozygous state produce an "30-fold higher level of the AR in the liver as compared with the nontransgenic control. Androgen inactivation via sulfonation of the hormone by dehydroepiandrosterone sulfotransferase (DST), an androgen-repressible enzyme, also contributes to the age-and sex-dependent regulation of hepatic androgen sensitivity. DST has a broad range of substrate specificity and is responsible for the age-and sex-specific activation ofcertain polycyclic aromatic hepatocarcinogens as well, by converting them to electrophilic sulfonated derivatives. In the transgenic female, the hepatic expression of DST was -4-fold lower than in normal females, a level comparable to that in normal males. The hPAH-AR mice will serve as a valuable model for studying the sex-and age-invariant expression of liver-specific genes, particularly those involved in the activation of environmental hepatocarcinogens such as the aromatic hydrocarbons.The androgen receptor (AR) is a member of the ligandactivated steroid/thyroid hormone receptor superfamily of transcription factors. Similar to expression of most other members of this superfamily, expression of AR is regulated in a tissue-, sex-and age-dependent manner. The rodent liver is an important androgen target, and a number of genes for hepatic proteins are either induced or repressed by androgenic hormones (1). For example, androgens upregulate hepatic synthesis of the rat pheromone-binding protein a2u-globulin, the mouse sex-limited protein (Slp), and carbonic anhydrase (CA) isozyme III, as well as various drug-and steroidmetabolizing enzymes, including specific cytochrome P450 isozymes (e.g., the steroid 2a-/16a-hydroxylase and fatty acid co-hydroxylase) and estrogen and other aryl sulfotransferases (2-9). Dehydroepiandrosterone sulfotransferase (DST), on the other hand, is downregulated by androgenic hormones (10, 11). Because of the central metabolic role of the liver, sexual dimorphism of the sex steroid-metabolizing enzymes plays a critical role in maintaining sex-specific hormonal homeostasis. Thus, DST, which inactivates androgenic steroids by sulfonation, is overexpressed in the female liver and is repressed in the male liver during the androgen-sensitive period of young adult life (10,11). This enzyme has a broad substrate specificity, and in addition to C-19 hydroxysteroids, it can use certain aromatic hydrocarbons such as benzo [a]pyrene, benz-[a]anthracene, pyrene, and their hydroxymethyl derivatives asThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in...